EULAV Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-45,000
| Closed | -$6.42M | – | 307 |
|
2019
Q2 | $6.42M | Sell |
45,000
-11,000
| -20% | -$1.57M | 0.24% | 111 |
|
2019
Q1 | $8.01M | Buy |
56,000
+20,000
| +56% | +$2.86M | 0.33% | 89 |
|
2018
Q4 | $4.46M | Sell |
36,000
-12,000
| -25% | -$1.49M | 0.22% | 122 |
|
2018
Q3 | $8.07M | Sell |
48,000
-1,000
| -2% | -$168K | 0.35% | 88 |
|
2018
Q2 | $8.44M | Sell |
49,000
-8,000
| -14% | -$1.38M | 0.39% | 86 |
|
2018
Q1 | $8.61M | Sell |
57,000
-12,000
| -17% | -$1.81M | 0.41% | 81 |
|
2017
Q4 | $9.29M | Sell |
69,000
-27,000
| -28% | -$3.64M | 0.44% | 74 |
|
2017
Q3 | $14M | Sell |
96,000
-4,000
| -4% | -$585K | 0.66% | 41 |
|
2017
Q2 | $15.6M | Sell |
100,000
-9,000
| -8% | -$1.4M | 0.76% | 35 |
|
2017
Q1 | $15.8M | Buy |
109,000
+46,000
| +73% | +$6.68M | 0.81% | 35 |
|
2016
Q4 | $6.87M | Buy |
+63,000
| New | +$6.87M | 0.37% | 91 |
|